Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity

Low density lipoprotein (LDL), which is a principal carrier for the delivery of cholesterol, has been used as a great candidate for the delivery of drugs to tumor based on the great requirements for cholesterol of many cancer cells. Mimicking the structure and composition of LDL, we designed a synth...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Hai-Tao, Li, Xin, Liang, De-Sheng, Qi, Xian-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239495/
https://www.ncbi.nlm.nih.gov/pubmed/27409176
http://dx.doi.org/10.18632/oncotarget.10493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239495/
https://www.ncbi.nlm.nih.gov/pubmed/27409176
http://dx.doi.org/10.18632/oncotarget.10493

Ejemplares similares